American Century Companies
LXEO icon

American Century Companies’s Lexeo Therapeutics LXEO Stock Holding History

American Century Companies’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.8K Buy
+18,855
New +$102K ﹤0.01% 2840
2026
Q1 		– Sell
-45,988
Closed -$457K – 2890
2025
Q4 		$457K Buy
45,988
+9,834
+27% +$89.7K ﹤0.01% 2539
2025
Q3 		$240K Buy
+36,154
New +$175K ﹤0.01% 2666

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

American Century Companies's LXEO Position: Q2 2026 in Review

American Century Companies opened a new position in Lexeo Therapeutics (LXEO) in Q2 2026: 18,855 shares worth $87.8K. The stake represents ﹤0.01% of the portfolio and ranks #2840 among its holdings. This is a return to the name: American Century Companies previously reported a position in LXEO as recently as Q4 2025.

American Century Companies first reported a position in LXEO in Q3 2025 and has held it in 3 quarters since. The position peaked at $457K in Q4 2025. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • American Century Companies held 18,855 shares of Lexeo Therapeutics worth $87.8K as of Q2 2026.
  • Lexeo Therapeutics was a new American Century Companies position in Q2 2026.
  • Lexeo Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2840 holding.
  • American Century Companies first reported a position in Lexeo Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • American Century Companies's Lexeo Therapeutics position peaked at $457K in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.